Which is better, active immunity or passive immunity?

Active immunity is better for long-term protection because your body produces memory cells, whereas passive immunity offers only temporary, short-lived defense without creating any memory.

How does active immunity develop in the body?

Active immunity develops when your immune system encounters a pathogen or vaccine and then produces its own antibodies and memory cells for future protection.

What are the main types of passive immunity?

Passive immunity occurs naturally through maternal antibodies crossing the placenta or through breast milk, and artificially through antibody injections like antivenom or immunoglobulin therapy.

Is passive immunity safe for everyone?

Passive immunity is generally safe but carries some risk of allergic reactions or serum sickness, especially with repeated doses of foreign antibodies from animal or human sources.

Can you switch from passive immunity to active immunity?

Yes, you can switch by getting vaccinated after receiving passive immunity, which then triggers your own immune system to build active, long-lasting protection.

How long does active immunity last compared to passive immunity?

Active immunity lasts for years or even a lifetime due to memory cells, while passive immunity typically lasts only a few weeks to a few months until the antibodies degrade.

What is a common beginner mistake when confusing active and passive immunity?

A common mistake is thinking vaccination provides passive immunity, but vaccines actually create active immunity because your own body makes the antibodies.

Are active immunity and passive immunity interchangeable in medical treatment?

No, they are not interchangeable because active immunity is used for prevention and long-term protection, while passive immunity is used for immediate, short-term treatment after exposure.

What is a real-world use case for passive immunity?

A real-world use case is giving tetanus immunoglobulin to an unvaccinated person with a deep wound, which provides immediate passive antibodies to prevent infection.

Difference Between

Difference Between Active Immunity and Passive Immunity

Written byNex Virox Team

Editorial Team

Reviewed byVarshal Nirbhavane

Senior SEO & Organic Growth Professional · 5+ years

Published: September 6, 202618 min read

Quick answer

The main difference between Active Immunity and Passive Immunity is that active immunity comes from your own immune system producing antibodies after exposure, while passive immunity comes from receiving ready-made antibodies from another source. Active Immunity is immunity your body creates itself, while Passive Immunity is borrowed, temporary protection from external antibodies.

Key takeaways

Core distinction: Active immunity develops from your own immune response, while passive immunity comes from borrowed antibodies.
How each works: Active immunity produces memory cells for long-term protection, whereas passive immunity provides immediate but temporary defense.
Cost and effort: Active immunity requires time or vaccination to build, while passive immunity delivers instant protection without immune system work.
Best-fit use case: Active immunity suits lifelong disease prevention, while passive immunity treats urgent exposures like rabies or snake bites.
Common decision mistake: Choosing passive immunity for routine prevention fails because its protection wanes quickly without lasting memory.

Table of Contents18 sections

Difference Between Active Immunity and Passive Immunity: Comparison Table

Aspect	Active Immunity	Passive Immunity
Definition	Immunity your own immune system generates after exposure to a pathogen or vaccine.	Immunity you receive from ready-made antibodies produced by another organism or person.
Purpose	Creates long-lasting protection by training the body to recognize and remember specific pathogens.	Provides immediate, temporary protection when rapid defense is needed before the immune system can respond.
Core Mechanism	Antigen exposure triggers B cells and T cells to produce antibodies and form memory cells.	Preformed antibodies are transferred directly into the bloodstream, bypassing the recipient's own immune response.
Antibody Source	Antibodies are produced by the individual's own plasma B cells after antigen stimulation.	Antibodies originate from an external donor, such as a mother, another human, or an animal.
Onset Speed	Protection develops slowly, typically taking days to weeks after exposure or vaccination.	Protection begins immediately, within hours of receiving the antibody preparation.
Duration	Lasts for years or a lifetime due to immunological memory cells that persist in the body.	Lasts only weeks to a few months because transferred antibodies degrade and are not replaced.
Memory Cells	Generates long-lived memory B cells and T cells that enable rapid response upon re-exposure.	Does not generate any memory cells, so no lasting immune recall is established.
Re-exposure Response	Produces a faster, stronger secondary response on subsequent encounters with the same pathogen.	Offers no enhanced response on re-exposure because the immune system was never primed.
Natural Acquisition	Occurs naturally when a person contracts an infection and recovers, developing natural immunity.	Occurs naturally when maternal IgG antibodies cross the placenta or IgA antibodies pass through breast milk.
Artificial Acquisition	Acquired artificially through vaccination with live-attenuated, inactivated, or subunit vaccines.	Acquired artificially through injection of immune globulin or antiserum preparations.
Vaccine Example	MMR vaccine induces active immunity against measles, mumps, and rubella viruses.	Tetanus immune globulin provides passive immunity immediately after a contaminated wound injury.
Natural Example	Recovery from chickenpox infection leaves lifelong active immunity against varicella-zoster virus.	A breastfed infant receives secretory IgA antibodies from colostrum and mature milk.
Immune System Role	Requires full participation of the innate and adaptive immune systems to generate a response.	Bypasses the recipient's immune system entirely, requiring no host immune activation.
Antibody Types	Produces multiple classes including IgG, IgM, IgA, and IgE tailored to the specific pathogen.	Transfers only the antibody classes present in the donor's serum, predominantly IgG.
Immunological Memory	Establishes durable memory that can persist for decades or even the entire lifetime.	Creates zero immunological memory, leaving the recipient susceptible after antibodies wane.
Booster Requirement	May require periodic booster doses to maintain protective antibody titers over time.	Requires repeat administration of antibodies for continued protection during ongoing exposure.
Protection Onset	Protection is delayed, usually appearing 1 to 2 weeks after the initial antigen exposure.	Protection is immediate, reaching peak levels within 24 to 48 hours after administration.
Protection Duration	Provides protection measured in years or decades, often lifelong after natural infection.	Provides protection measured in weeks, typically 3 to 12 weeks depending on antibody half-life.
Antibody Half-life	Antibodies are continuously produced by plasma cells, maintaining stable circulating levels.	Transferred IgG has a half-life of roughly 21 to 28 days before being cleared from circulation.
Pathogen Coverage	Confers broad, specific protection against the exact pathogen strain that triggered the response.	Confers narrow protection limited to the specific antigens present in the donor antibody preparation.
Variant Response	Can adapt and produce new antibodies if memory cells recognize mutated variants of the pathogen.	Cannot adapt to new variants because no new antibody production occurs in the recipient.
Side Effect Profile	May cause mild local reactions like soreness or fever during the normal immune activation process.	Carries risk of serum sickness or anaphylaxis from foreign proteins in animal-derived antisera.
Cost of Acquisition	Vaccines are inexpensive to produce and administer, costing a few dollars per dose in public programs.	Immune globulin preparations are costly due to plasma fractionation and donor screening processes.
Production Method	Vaccines are manufactured using cultured pathogens, recombinant proteins, or genetic material.	Antibodies are harvested from pooled human plasma, animal serum, or monoclonal cell cultures.
Administration Route	Vaccines are given via intramuscular, subcutaneous, oral, or intranasal routes depending on type.	Antibodies are given via intramuscular, intravenous, or subcutaneous injection routes only.
Typical Recipients	Healthy infants, children, and adults receiving routine childhood and adult vaccination schedules.	Immunocompromised patients, exposed unvaccinated individuals, and newborns of infected mothers.
Clinical Use Case	Routine pediatric vaccination programs prevent measles, polio, and hepatitis B across populations.	Post-exposure prophylaxis for rabies, hepatitis B, and tetanus in unvaccinated or high-risk patients.
Immunocompromised Fit	May produce weak or inadequate responses in severely immunocompromised patients with low T-cell function.	Works effectively in immunocompromised patients because it does not require host immune competence.
Herd Immunity	Contributes to herd immunity by reducing transmission when high vaccination coverage is achieved.	Does not contribute to herd immunity because protection is individual and transient.
Best-Fit Scenario	Best for long-term prevention in healthy populations through routine vaccination programs.	Best for urgent protection in exposed, unvaccinated, or immunodeficient individuals needing immediate defense.

What Is Active Immunity?

Active immunity is protection your body builds after encountering a pathogen. It produces its own antibodies and memory cells. This defense develops after infection or vaccination, creating long-lasting immunity. It exists to provide durable, specific protection against future exposures to the same threat.

Definition of Active Immunity

Active immunity is the adaptive immune response triggered when an individual's own immune system processes an antigen and generates antibodies and memory lymphocytes. This process occurs naturally through infection or artificially through vaccination. The resulting protection is typically prolonged, often lasting years or a lifetime.

Key Characteristics of Active Immunity

Characteristic	What It Means in Practice
Antibody production	Your plasma cells manufacture antibodies tailored to the specific antigen encountered.
Memory cells formed	B and T memory cells persist for years, enabling faster response upon re-exposure.
Onset is slow	Protection takes days or weeks to develop, as the immune system must respond first.
Duration is long	Immunity often lasts for years or a lifetime, depending on the pathogen.
Immunological memory	Subsequent exposures trigger a rapid, amplified secondary immune response.
Specificity is high	The response targets one exact antigen, not a broad range of pathogens.
Natural acquisition	Occurs when you contract an infection and your body fights it off.
Artificial acquisition	Occurs via vaccination, which introduces a harmless form of the antigen.
No transfer involved	Antibodies are not received from another source; your body makes them.
Requires antigen exposure	The process cannot begin without first encountering the specific pathogen or vaccine.

Common Examples of Active Immunity

Chickenpox infection – contracting the virus triggers lifelong protective immunity against reinfection.
MMR vaccine – a live attenuated vaccine induces durable immunity against measles, mumps and rubella.
COVID-19 vaccination – mRNA vaccines prompt your cells to produce spike protein, generating protective antibodies.
Hepatitis B recovery – surviving an acute infection yields long-term immunity via surface antibodies.
Tetanus toxoid vaccine – inactivated toxin stimulates antibody production, requiring boosters every ten years.
Influenza infection – natural recovery creates strain-specific immunity, though it wanes over time.
Polio vaccine (OPV) – oral live vaccine produces gut immunity and herd protection in communities.
Rubella infection – prior infection confers lifelong immunity, often checked during pregnancy screening.
HPV vaccine – virus-like particles trigger antibody responses that prevent cervical cancer-causing strains.
Malaria exposure – repeated natural infections build partial, non-sterilising immunity that reduces severity.

Advantages and Limitations of Active Immunity

Advantages	Limitations
Provides long-lasting protection, often spanning years or an entire lifetime.	Slow onset means no immediate protection during an active outbreak or exposure.
Creates immunological memory that strengthens future responses to the same pathogen.	Requires a functioning immune system; immunocompromised individuals may not respond adequately.
Vaccination achieves this safely without causing the actual disease.	Some vaccines require multiple doses or boosters to maintain effective protection.
Natural infection confers robust immunity that is typically highly specific.	Natural infection carries real risks of severe illness, complications or death.
Reduces transmission within populations, contributing to herd immunity.	Immune response varies widely between individuals based on age, genetics and health.
No external antibodies are needed, so the body manages its own defense fully.	Antigenic drift or shift in pathogens can evade existing immunity over time.
Memory B cells enable rapid antibody production upon re-exposure.	Development takes days to weeks, leaving a window of vulnerability after exposure.
Vaccines can be engineered to target multiple strains in a single shot.	Certain pathogens, like HIV, evade or suppress the immune response effectively.
Protection is not passive, so no risk of antibody degradation from an external source.	Booster shots are necessary for several vaccines, such as tetanus and pertussis.
Effective against a wide range of viral and bacterial pathogens.	Cannot be induced for toxins like snake venom, which require passive antitoxin treatment.

What Is Passive Immunity?

Passive immunity is the transfer of ready-made antibodies from one individual to another, providing immediate but temporary protection. It does not require the recipient's immune system to respond, so protection begins instantly. This mechanism exists to shield vulnerable people during the critical window before their own immunity can develop.

Definition of Passive Immunity

Passive immunity is a form of acquired immunity where pre-formed antibodies or sensitized T-cells are transferred from a donor to a recipient, conferring instant, short-lived protection. The recipient's immune system plays no active role in producing these defenses. Protection lasts only as long as the transferred antibodies survive in the bloodstream.

Key Characteristics of Passive Immunity

Characteristic	What It Means in Practice
Immediate onset	Protection begins within hours of antibody transfer, unlike active immunity which takes days or weeks.
Short duration	Antibodies degrade naturally, so protection typically fades within weeks to a few months.
No memory cells	The recipient gains no immunological memory, so repeated exposure requires repeated antibody doses.
Passive transfer	Antibodies are donated, not produced by the recipient's own immune system.
No immune response	The recipient's B-cells and T-cells remain inactive, avoiding any risk of immune system activation.
Natural occurrence	Occurs naturally via maternal antibodies crossing the placenta or through breast milk.
Artificial induction	Can be induced medically via immunoglobulin injections from pooled donor plasma.
Rapid protection	Ideal for post-exposure prophylaxis where time is critical, such as rabies or tetanus.
Limited specificity	Protection is limited to the exact pathogens the donated antibodies target.
Dose-dependent	Higher antibody doses provide stronger but still temporary protection, requiring repeat dosing.

Common Examples of Passive Immunity

Maternal IgG transfer – Antibodies cross the placenta during the third trimester, protecting the fetus before birth.
Breast milk IgA – Secretory IgA in colostrum and milk guards the infant's gut and respiratory tract.
Rabies post-exposure immunoglobulin – Given immediately after a bite to neutralize the virus before it reaches nerves.
Tetanus antitoxin – Provides instant antitoxin coverage for unvaccinated patients with contaminated wounds.
Hepatitis B immunoglobulin – Given to newborns of infected mothers to block vertical transmission.
Varicella-zoster immunoglobulin – Protects high-risk infants or immunocompromised patients exposed to chickenpox.
COVID-19 convalescent plasma – Transfused antibodies from recovered donors to treat acute severe infection.
Snake antivenom – Pre-formed antibodies neutralize venom toxins immediately after a bite.
Botulism antitoxin – Administered after suspected exposure to block toxin activity in the bloodstream.
RhIG for Rh-negative mothers – Prevents maternal sensitization against Rh-positive fetal blood cells.

Advantages and Limitations of Passive Immunity

Advantages	Limitations
Instant protection for emergencies like rabies or tetanus exposure.	Protection is transient, often fading within weeks, requiring repeat doses.
Safe for immunocompromised patients who cannot mount an active response.	No memory cells form, so the recipient remains fully susceptible after antibodies decay.
Useful for newborns whose immune systems are immature.	Risk of serum sickness or allergic reactions to foreign proteins in the injection.
Effective for post-exposure prophylaxis where timing is critical.	Limited supply of human plasma donors restricts large-scale availability.
Bypasses the delay of active immunity, which takes 1-2 weeks.	Antibody half-life is short, so protection is not durable or long-lasting.
Provides broad coverage from pooled donor immunoglobulins.	Can cause immune suppression if antibodies interfere with the recipient's own response.
No risk of vaccine-related side effects like fever or soreness.	Potential for blood-borne pathogen transmission despite screening.
Ideal for travelers needing immediate protection before departure.	High cost of immunoglobulin preparations limits routine use.
Can neutralize toxins directly without requiring cellular activation.	Repeated doses can lead to anti-antibody formation, reducing efficacy over time.
Effective in outbreak settings for rapid containment of spread.	No long-term epidemiological benefit, as the population remains susceptible after waning.

Similarities Between Active Immunity and Passive Immunity

Shared Aspect	How Active Immunity and Passive Immunity Are Alike
Core Purpose	Both active immunity and passive immunity exist to protect the body against specific infectious pathogens.
Immune Category	Active immunity and passive immunity are both forms of adaptive immunity that target specific antigens.
Primary Input	Both active immunity and passive immunity require exposure to a specific antigen to initiate protection.
Final Output	Both active immunity and passive immunity ultimately produce a state of resistance to a particular disease.
Key Players	Active immunity and passive immunity both rely on antibodies to neutralize or mark pathogens for destruction.
Natural Route	Both active immunity and passive immunity can occur naturally through infection or maternal transfer.
Artificial Route	Both active immunity and passive immunity can be induced artificially through vaccination or antibody injection.
Specificity	Both active immunity and passive immunity provide protection that is specific to one particular pathogen.
Immune Memory	Both active immunity and passive immunity involve the immune system's recognition of a specific foreign antigen.
B-Cell Role	Both active immunity and passive immunity depend on B cells or their antibody products for function.
Protective Goal	Both active immunity and passive immunity aim to prevent infection or reduce the severity of a disease.
Antigen Dependence	Both active immunity and passive immunity are triggered by a specific antigen, not by general stimulation.
Humoral Link	Both active immunity and passive immunity are primarily mediated by the humoral branch of adaptive immunity.
Transferability	Both active immunity and passive immunity can be transferred from one individual to another via antibodies.
Clinical Use	Both active immunity and passive immunity are used clinically to prevent or treat infectious diseases.
Vaccination Basis	Both active immunity and passive immunity are foundational concepts in vaccine development and immunotherapy.
Pathogen Target	Both active immunity and passive immunity are designed to combat bacteria, viruses, and other microbes.
Booster Potential	Both active immunity and passive immunity can be boosted with repeated exposure or additional antibody doses.
Risk Profile	Both active immunity and passive immunity carry a small risk of allergic or adverse reactions.
Measurement Method	Both active immunity and passive immunity are measured by detecting antibody levels in the blood.
Serological Marker	Both active immunity and passive immunity produce detectable antibodies that confirm immune status.
Time to Onset	Both active immunity and passive immunity require a delay before full protective effect is achieved.
Durability Range	Both active immunity and passive immunity have a duration that varies from weeks to years.
System Integration	Both active immunity and passive immunity work alongside innate immunity to provide complete defense.
Regulatory Standard	Both active immunity and passive immunity are subject to strict regulatory oversight for medical use.
Cost Factor	Both active immunity and passive immunity involve significant costs for development and administration.
Failure Mode	Both active immunity and passive immunity can fail if the pathogen mutates or antibody levels drop.
Maintenance Need	Both active immunity and passive immunity may require repeat administration to maintain protective levels.
Population Use	Both active immunity and passive immunity are applied to protect individuals and vulnerable communities.
Long-Term Goal	Both active immunity and passive immunity aim to reduce disease spread and improve public health outcomes.

Active Immunity or Passive Immunity: Which Should You Choose?

Choose Active Immunity for long-term protection because your immune system builds lasting memory cells. Choose Passive Immunity for immediate, short-term defense when time is critical. The single deciding variable is speed versus duration: passive acts in hours, active takes weeks but lasts for years.

When to Use Active Immunity

Choose Active Immunity when you need protection lasting years or a lifetime, such as routine childhood vaccinations or annual flu shots. It suits healthy individuals with functioning immune systems who can wait 2-4 weeks for full antibody production. It is also the right choice for travelers planning trips months ahead.

When to Use Passive Immunity

Choose Passive Immunity when you need immediate protection within hours, such as after a rabies or tetanus exposure. It is critical for newborns of infected mothers, immunocompromised patients, or unvaccinated individuals facing an active outbreak. Use it when time to infection is shorter than vaccine response time.

Common Misconceptions About Active Immunity and Passive Immunity

Common Myth	The Reality
Active immunity only comes from getting a vaccine shot.	Active immunity also develops naturally when your immune system fights off a real infection, not just from vaccines.
Passive immunity lasts for many years after birth.	Passive immunity from maternal antibodies typically fades within weeks to a few months after birth.
Active immunity provides protection instantly after exposure.	Active immunity takes days or weeks to develop because your body must produce antibodies and memory cells first.
Passive immunity requires your immune system to work hard.	Passive immunity provides ready-made antibodies, so your own immune system does not need to produce them.
Vaccines give you passive immunity against diseases.	Vaccines trigger active immunity by prompting your immune system to create its own lasting antibodies and memory.
Active immunity is always permanent and lasts a lifetime.	Active immunity duration varies; some infections give lifelong protection, while others require booster shots over time.
Passive immunity is stronger than active immunity overall.	Passive immunity acts fast but is temporary, while active immunity is slower yet provides longer-lasting protection.
You cannot get passive immunity from any medical treatment.	Passive immunity is given through treatments like immunoglobulin injections or monoclonal antibody therapies.
Active immunity only happens after you get sick.	Active immunity also develops safely through vaccination without you ever experiencing the disease symptoms.
Passive immunity trains your body to fight future infections.	Passive immunity does not create memory cells, so your body gains no lasting ability to fight that pathogen later.
Breastfeeding gives the baby permanent active immunity.	Breast milk provides passive immunity via secretory IgA antibodies, which only protect the baby temporarily.
Active immunity and passive immunity are the exact same process.	Active immunity involves your own antibody production, while passive immunity involves receiving antibodies from another source.
Once you have passive immunity, you never need vaccines.	Passive immunity wanes quickly, so you still need vaccines to build your own long-term active immunity.
Antibodies from passive immunity stay in your blood forever.	Passive antibodies are broken down by the body, usually within weeks to a few months after they are introduced.
Active immunity cannot be transferred from one person to another.	Active immunity is not directly transferable, but antibodies can be passed temporarily, which is passive immunity.
Passive immunity is only relevant for newborn babies.	Passive immunity is also used for adults after exposure to rabies, tetanus, or hepatitis B.
Your immune system remembers passive antibody protection.	Your immune system does not form memory cells from passive immunity, so it forgets the pathogen completely.
Active immunity takes effect faster than passive immunity.	Passive immunity acts immediately, while active immunity takes several days or weeks to build up protection.
Natural active immunity is always better than vaccine-induced immunity.	Vaccine-induced active immunity provides protection without the severe risks of natural infection, making it safer.
Passive immunity can be boosted by eating certain foods.	No food creates passive immunity; only receiving external antibodies from a mother or medical product provides it.
Active immunity never requires a booster shot.	Some active immunity, like tetanus or pertussis, fades and requires periodic booster vaccinations to maintain protection.
Passive immunity is a type of long-term vaccination.	Passive immunity is temporary antibody transfer, not vaccination, which always aims to trigger active immune memory.
Antibodies are only produced during active immunity responses.	Antibodies are present in both types, but active immunity produces them yourself while passive immunity borrows them.
Passive immunity protects against all future strains of a virus.	Passive immunity targets only the specific pathogen or strain the donated antibodies were made for.
Active immunity is only triggered by viruses, not bacteria.	Active immunity develops against bacteria too, such as through vaccines for tetanus, pneumonia, and whooping cough.
Getting antibodies from your mother is active immunity.	Maternal antibody transfer is passive immunity because the baby receives ready-made antibodies instead of making them.
Passive immunity has no role in treating active diseases.	Passive immunity treats active infections like rabies or botulism by neutralizing toxins while your immunity builds.
Active immunity cannot be measured in your blood.	Active immunity is measurable through antibody titers, which show the level of protective antibodies you produced.
Passive immunity is permanent after a single injection.	A single passive immunity injection offers temporary protection, often lasting only a few weeks to months.
Active immunity only protects you, not others around you.	Active immunity from vaccination contributes to herd immunity, indirectly protecting vulnerable people in the community.

Conclusion

Difference Between Active Immunity and Passive Immunity comes down to antibody origin. Active immunity develops when your body produces antibodies after infection or vaccination, offering long-lasting protection. Passive immunity provides borrowed, temporary antibodies from a mother or antibody treatment. Choose active immunity for durable defense; choose passive immunity for immediate, short-term protection.

FAQs on Difference Between Active Immunity and Passive Immunity

What is the main difference between active immunity and passive immunity?: Active immunity comes from your own immune system making antibodies after exposure or vaccination, while passive immunity involves receiving ready-made antibodies from another source.
Which is better, active immunity or passive immunity?: Active immunity is better for long-term protection because your body produces memory cells, whereas passive immunity offers only temporary, short-lived defense without creating any memory.
How does active immunity develop in the body?: Active immunity develops when your immune system encounters a pathogen or vaccine and then produces its own antibodies and memory cells for future protection.
What are the main types of passive immunity?: Passive immunity occurs naturally through maternal antibodies crossing the placenta or through breast milk, and artificially through antibody injections like antivenom or immunoglobulin therapy.
Is passive immunity safe for everyone?: Passive immunity is generally safe but carries some risk of allergic reactions or serum sickness, especially with repeated doses of foreign antibodies from animal or human sources.
Can you switch from passive immunity to active immunity?: Yes, you can switch by getting vaccinated after receiving passive immunity, which then triggers your own immune system to build active, long-lasting protection.
How long does active immunity last compared to passive immunity?: Active immunity lasts for years or even a lifetime due to memory cells, while passive immunity typically lasts only a few weeks to a few months until the antibodies degrade.
What is a common beginner mistake when confusing active and passive immunity?: A common mistake is thinking vaccination provides passive immunity, but vaccines actually create active immunity because your own body makes the antibodies.
Are active immunity and passive immunity interchangeable in medical treatment?: No, they are not interchangeable because active immunity is used for prevention and long-term protection, while passive immunity is used for immediate, short-term treatment after exposure.
What is a real-world use case for passive immunity?: A real-world use case is giving tetanus immunoglobulin to an unvaccinated person with a deep wound, which provides immediate passive antibodies to prevent infection.